← Back to search results

planningFind a Tender · planning Update

Research Analysis Platform 2.0

Buyer: UK BIOBANK LIMITED →

BuyerUK BIOBANK LIMITED
Statusplanning
DeadlineNot published
ValueValue not published
Published10 Dec 2025

What is being bought

UK Biobank ("UKB") currently hosts a cloud-based health Research Analysis Platform which makes research projects and data accessible to researchers ("RAP"). The current RAP was procured by UKB in 2020 and was developed by DNAnexus, in collaboration with, and cloud infrastructure provided by, Amazon Web Services. As part of a series of changes to implement UKB's strategy to create a more secure data environment, UKB intends to initiate a procurement exercise in 2027 for the development of a new RAP ("RAP2.0") to take account of advances in technology over the past 5 years and its future requirements. The RAP2.0 is anticipated to be the default way that most researchers will access and analyse UKB's biomedical database and it is anticipated to comprise one or more software platforms or data analysis services that work together to meet the diverse functional needs to the research community. UKB currently intends to undertake separate procurements in relation to (i) the RAP2.0, (ii) cloud infrastructure which will host data on RAP2.0, and (iii) the development of an Output Checking System (formerly badged as Airlock Software) to control the extraction of data held by UKB for research purposes, whilst ensuring the ongoing security and confidentiality of the data and confidentiality of the data ("OCS"). UKB has established an informatics working group consisting of senior experts who will provide guidance to help develop the requirements for the technology listed at (i) - (iii) above. It is necessary for the procurement exercises for cloud infrastructure services to be completed before preliminary market engagement can take place with suppliers and users regarding the requirements and strategic approach to the new RAP2.0. The identity of the cloud services infrastructure will inform the approach to the RAP2.0 procurement to ensure the compatibility of the technology underlying the platform or platforms. It is currently intended that such preliminary market engagement for RAP2.0 will take place in 2027, followed by the competitive procurement exercise for the new RAP2.0. The current contract for the enablement of the RAP with DNAnexus expires in June 2026. It is intended that this contract will be amended in January 2026 to extend the services through to June 2028. It is currently envisaged that the first procurement to be undertaken will relate to the OCS (in the first half of 2026), followed by a procurement for cloud infrastructure (in the second half of 2026), followed by the procurement of the RAP2.0 in 2027. This Preliminary Market Engagement Notice relates to the development of the RAP2.0. Separate Preliminary Market Engagement Notices were published for cloud infrastructure and OCS in April 2025 and are being updated. Further updates regarding preliminary market engagement activities will be included in an update to this notice, as appropriate.

Delivery location

UKC, GB · UKD, GB · UKE, GB · UKF, GB · UKG, GB · UKH, GB · UKI, GB · UKJ, GB · UKK, GB

Categories

Computer platforms 30211300Industry specific software package 48100000Data-processing services 72310000Database services 72320000Computer-related services 72500000

Lot details

Lot 1

No lot description published.

Statusplanning
Contract periodFrom 1 Oct 2027 to 30 Sept 2033

What is included

ItemCategoryQuantity
1Computer platforms, Industry specific software package, Data-processing services, Database services, Computer-related servicesNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 30. The category anchor is Computer platforms (30211300); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 305732 median · 8.5 average (190 of 573 with a bid count)2.8 average (208 of 573 with named award suppliers)Not published
Same buyer1Not publishedNot publishedNot published
Delivery region: UKC501 median · 3.1 average (22 of 50 with a bid count)1.2 average (26 of 50 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetValue not published
No-engagement rationaleNot published
Planning documents1
Planning milestones1
MilestoneTypeDueStatus
UKB currently envisages that, in addition to the work of the informatics working group, it may engage with suppliers, researchers and users prior to launch of the RAP2.0 procurement. Further details of any proposed engagement would be set out in a further preliminary market engagement notice including the activities to be undertaken (which may take place in stages and may take the form of one-to-one meetings with suppliers, researchers and/or users and/or requests to complete written questionnaires). Interested organisations should register their interest in this potential opportunity via the following link: tenders@ukbiobank.ac.ukengagement9 Mar 2026scheduled

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-050680
Latest release ID081714-2025
Latest release timestampWed Dec 10 2025 17:42:54 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanning
Procurement methodNot published
Procurement method detailsNot published
Main procurement categoryservices
Above thresholdYes
Legal basis2023/54
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender valueNot published
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
10 Dec 2025planningUpdate081714-2025

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "081714-2025",
  "tag": [
    "planningUpdate"
  ],
  "date": "2025-12-10T17:42:54Z",
  "ocid": "ocds-h6vhtk-050680",
  "buyer": {
    "id": "GB-COH-04978912",
    "name": "UK BIOBANK LIMITED"
  },
  "tender": {
    "id": "UKB0022",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "contractPeriod": {
          "endDate": "2033-09-30T23:59:59+01:00",
          "startDate": "2027-10-01T00:00:00+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKC",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKD",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKE",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKF",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKG",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKH",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKI",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKJ",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "30211300",
            "scheme": "CPV",
            "description": "Computer platforms"
          },
          {
            "id": "48100000",
            "scheme": "CPV",
            "description": "Industry specific software package"
          },
          {
            "id": "72310000",
            "scheme": "CPV",
            "description": "Data-processing services"
          },
          {
            "id": "72320000",
            "scheme": "CPV",
            "description": "Database services"
          },
          {
            "id": "72500000",
            "scheme": "CPV",
            "description": "Computer-related services"
          }
        ]
      }
    ],
    "title": "Research Analysis Platform 2.0",
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "UK Biobank (\"UKB\") currently hosts a cloud-based health Research Analysis Platform which makes research projects and data accessible to researchers (\"RAP\"). The current RAP was procured by UKB in 2020 and was developed by DNAnexus, in collaboration with, and cloud infrastructure provided by, Amazon Web Services.\nAs part of a series of changes to implement UKB's strategy to create a more secure data environment, UKB intends to initiate a procurement exercise in 2027 for the development of a new RAP (\"RAP2.0\") to take account of advances in technology over the past 5 years and its future requirements. The RAP2.0 is anticipated to be the default way that most researchers will access and analyse UKB's biomedical database and it is anticipated to comprise one or more software platforms or data analysis services that work together to meet the diverse functional needs to the research community.\nUKB currently intends to undertake separate procurements in relation to (i) the RAP2.0, (ii) cloud infrastructure which will host data on RAP2.0, and (iii) the development of an Output Checking System (formerly badged as Airlock Software) to control the extraction of data held by UKB for research purposes, whilst ensuring the ongoing security and confidentiality of the data and confidentiality of the data (\"OCS\"). UKB has established an informatics working group consisting of senior experts who will provide guidance to help develop the requirements for the technology listed at (i) - (iii) above.\nIt is necessary for the procurement exercises for cloud infrastructure services to be completed before preliminary market engagement can take place with suppliers and users regarding the requirements and strategic approach to the new RAP2.0. The identity of the cloud services infrastructure will inform the approach to the RAP2.0 procurement to ensure the compatibility of the technology underlying the platform or platforms.  It is currently intended that such preliminary market engagement for RAP2.0 will take place in 2027, followed by the competitive procurement exercise for the new RAP2.0. The current contract for the enablement of the RAP with DNAnexus expires in June 2026.  It is intended that this contract will be amended in January 2026 to extend the services through to June 2028. \nIt is currently envisaged that the first procurement to be undertaken will relate to the OCS (in the first half of 2026), followed by a procurement for cloud infrastructure (in the second half of 2026), followed by the procurement of the RAP2.0 in 2027. \nThis Preliminary Market Engagement Notice relates to the development of the RAP2.0. Separate Preliminary Market Engagement Notices were published for cloud infrastructure and OCS in April 2025 and are being updated. Further updates regarding preliminary market engagement activities will be included in an update to this notice, as appropriate.",
    "aboveThreshold": true,
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-COH-04978912",
      "name": "UK BIOBANK LIMITED",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKD35",
        "country": "GB",
        "locality": "Stockport",
        "postalCode": "SK3 0SA",
        "countryName": "United Kingdom",
        "streetAddress": "Units 1 & 2 Spectrum Way,"
      },
      "details": {
        "classifications": [
          {
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - sub-central government"
          }
        ]
      },
      "identifier": {
        "id": "04978912",
        "scheme": "GB-COH"
      },
      "contactPoint": {
        "email": "tenders@ukbiobank.ac.uk"
      },
      "additionalIdentifiers": [
        {
          "id": "PXGY-4832-TWCN",
          "scheme": "GB-PPON"
        }
      ]
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "081714-2025",
        "url": "https://www.find-tender.service.gov.uk/Notice/081714-2025",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2025-12-10T17:42:54Z"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-03-09T23:59:59Z",
        "description": "UKB currently envisages that, in addition to the work of the informatics working group, it may engage with suppliers, researchers and users prior to launch of the RAP2.0 procurement.  Further details of any proposed engagement would be set out in a further preliminary market engagement notice including the activities to be undertaken (which may take place in stages and may take the form of one-to-one meetings with suppliers, researchers and/or users and/or requests to complete written questionnaires).\nInterested organisations should register their interest in this potential opportunity via the following link: tenders@ukbiobank.ac.uk"
      }
    ]
  },
  "initiationType": "tender"
}
Complete JSON history (1 releases)
10 Dec 2025 · 081714-2025 · planningUpdate
{
  "id": "081714-2025",
  "tag": [
    "planningUpdate"
  ],
  "date": "2025-12-10T17:42:54Z",
  "ocid": "ocds-h6vhtk-050680",
  "buyer": {
    "id": "GB-COH-04978912",
    "name": "UK BIOBANK LIMITED"
  },
  "tender": {
    "id": "UKB0022",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "contractPeriod": {
          "endDate": "2033-09-30T23:59:59+01:00",
          "startDate": "2027-10-01T00:00:00+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKC",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKD",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKE",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKF",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKG",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKH",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKI",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKJ",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "30211300",
            "scheme": "CPV",
            "description": "Computer platforms"
          },
          {
            "id": "48100000",
            "scheme": "CPV",
            "description": "Industry specific software package"
          },
          {
            "id": "72310000",
            "scheme": "CPV",
            "description": "Data-processing services"
          },
          {
            "id": "72320000",
            "scheme": "CPV",
            "description": "Database services"
          },
          {
            "id": "72500000",
            "scheme": "CPV",
            "description": "Computer-related services"
          }
        ]
      }
    ],
    "title": "Research Analysis Platform 2.0",
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "UK Biobank (\"UKB\") currently hosts a cloud-based health Research Analysis Platform which makes research projects and data accessible to researchers (\"RAP\"). The current RAP was procured by UKB in 2020 and was developed by DNAnexus, in collaboration with, and cloud infrastructure provided by, Amazon Web Services.\nAs part of a series of changes to implement UKB's strategy to create a more secure data environment, UKB intends to initiate a procurement exercise in 2027 for the development of a new RAP (\"RAP2.0\") to take account of advances in technology over the past 5 years and its future requirements. The RAP2.0 is anticipated to be the default way that most researchers will access and analyse UKB's biomedical database and it is anticipated to comprise one or more software platforms or data analysis services that work together to meet the diverse functional needs to the research community.\nUKB currently intends to undertake separate procurements in relation to (i) the RAP2.0, (ii) cloud infrastructure which will host data on RAP2.0, and (iii) the development of an Output Checking System (formerly badged as Airlock Software) to control the extraction of data held by UKB for research purposes, whilst ensuring the ongoing security and confidentiality of the data and confidentiality of the data (\"OCS\"). UKB has established an informatics working group consisting of senior experts who will provide guidance to help develop the requirements for the technology listed at (i) - (iii) above.\nIt is necessary for the procurement exercises for cloud infrastructure services to be completed before preliminary market engagement can take place with suppliers and users regarding the requirements and strategic approach to the new RAP2.0. The identity of the cloud services infrastructure will inform the approach to the RAP2.0 procurement to ensure the compatibility of the technology underlying the platform or platforms.  It is currently intended that such preliminary market engagement for RAP2.0 will take place in 2027, followed by the competitive procurement exercise for the new RAP2.0. The current contract for the enablement of the RAP with DNAnexus expires in June 2026.  It is intended that this contract will be amended in January 2026 to extend the services through to June 2028. \nIt is currently envisaged that the first procurement to be undertaken will relate to the OCS (in the first half of 2026), followed by a procurement for cloud infrastructure (in the second half of 2026), followed by the procurement of the RAP2.0 in 2027. \nThis Preliminary Market Engagement Notice relates to the development of the RAP2.0. Separate Preliminary Market Engagement Notices were published for cloud infrastructure and OCS in April 2025 and are being updated. Further updates regarding preliminary market engagement activities will be included in an update to this notice, as appropriate.",
    "aboveThreshold": true,
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-COH-04978912",
      "name": "UK BIOBANK LIMITED",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKD35",
        "country": "GB",
        "locality": "Stockport",
        "postalCode": "SK3 0SA",
        "countryName": "United Kingdom",
        "streetAddress": "Units 1 & 2 Spectrum Way,"
      },
      "details": {
        "classifications": [
          {
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - sub-central government"
          }
        ]
      },
      "identifier": {
        "id": "04978912",
        "scheme": "GB-COH"
      },
      "contactPoint": {
        "email": "tenders@ukbiobank.ac.uk"
      },
      "additionalIdentifiers": [
        {
          "id": "PXGY-4832-TWCN",
          "scheme": "GB-PPON"
        }
      ]
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "081714-2025",
        "url": "https://www.find-tender.service.gov.uk/Notice/081714-2025",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2025-12-10T17:42:54Z"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-03-09T23:59:59Z",
        "description": "UKB currently envisages that, in addition to the work of the informatics working group, it may engage with suppliers, researchers and users prior to launch of the RAP2.0 procurement.  Further details of any proposed engagement would be set out in a further preliminary market engagement notice including the activities to be undertaken (which may take place in stages and may take the form of one-to-one meetings with suppliers, researchers and/or users and/or requests to complete written questionnaires).\nInterested organisations should register their interest in this potential opportunity via the following link: tenders@ukbiobank.ac.uk"
      }
    ]
  },
  "initiationType": "tender"
}